Patients from high-risk regions infected with HIV: Recognition can prevent serious complications;Patiënten uit hoog-risicogebieden met hiv-infectie

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 48, 2012, Pages

  Wouthuyzen Bakker, Marjan ^a   Bierman, Wouter F W ^a   Van Assen, Sander ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RECOGNITION; ADULT; CASE REPORT; DELAYED DIAGNOSIS; FEMALE; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ADULT; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED;

EID: 84873696571     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26:833-54 Medline. doi:10.1016/j.ncl.2008.03.007
2. Ende van der ME. Immuunreconstitutiesyndroom: een complicatie van antiretrovirale therapie bij HIV-positieve patiënten. Tijdschr Infectieziekten. 2006;1:48-54
3. World Health Organization. Report on the global AIDS epidemic. Geneva: UNAIDS; 2011.
4. Hiv monitoring, jaarverslag 2011. www.hiv-monitoring.nl/nederlands/over- shm/jaarverslagen, geraadpleegd op 28 september 2012 link.
5. Simon V, Ho DD, Abdool Karim Q. Hiv/aids epidemiology, pathogenesis, prevention and treatment. Lancet. 2006;368:489-504 Medline. doi:10.1016/S0140- 6736(06)69157-5
6. Smith AD, Tapsoba P, Peshu N, et al. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet. 2009;374:416-22 Medline. doi:10.1016/S0140-6736(09)61118-1
7. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with longterm nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995;332:209-16 Medline. doi:10.1056/NEJM199501263320402
8. Waters L, Sabin CA. Late HIV presentation: epidemiology, clinical implications and management. Expert Rev Anti Infect Ther. 2011;9:877-89 Medline. doi:10.1586/eri.11.106
9. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ. 1989;299:154-7 Medline. doi:10.1136/bmj.299.6692.154
10. Brinkman K, Prins JM, Jurriaans S, et al. Primaire HIV-infectie: mononucleosis-infectiosa-achtig ziektebeeld met therapeutische mogelijkheden. Ned Tijdschr Geneeskd. 1999;143:1129-33 NTvG Medline.
11. Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ. 1999;48:1-22 Medline.
12. Phillips AN, Elford J, Sabin C, et al. Immunodeficiency and the risk of death in HIV infection. JAMA. 1992;268:2662-6 Medline. doi:10.1001/jama.1992. 03490190062032
13. Maurer TA. Perspective. Dermatologic manifestations of HIV infection. Top HIV Med. 2005;13:149-54 Medline.
14. Serrano P, Hernández N, Arroya JA, et al. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis. 2007;44:e57-e61. doi:10.1086/511876
15. Wanyenze RK, Kamya MR, Fatch R et al. Missed opportunities for HIV testing and late stage diagnosis among hiv-infected patients in Uganda. PLoS One. 2011;6:1-11.
16. Hermans L, Wensing A, Hoepelman A, et al. Delayed HIV testing in internal medicine clinics - a missed opportunity. Neth J Med. 2012;70:69-73 Medline.
17. Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol. 2008;26:4834-42 Medline. doi:10.1200/JCO.2008.16.8252